PainChek Says Scotland Care System Trial Confirmed Clinical Benefits from App Use, Shares Up 4%

MT Newswires Live
2025/09/17

PainChek (ASX:PCK) said the PainChek Adult App was trialed in the Scottish care system in a Scottish government-funded pilot, and an independent evaluation confirmed clinical benefits in using the app, including up to 40% reduction in falls and up to 27% reduction in dependency and care needs, according to a Wednesday Australian bourse filing.

The app was independently assessed by Edinburgh Napier University in collaboration with the Scottish Care Inspectorate, and the evaluation also confirmed improvements in clinical outcomes, such as a 25% reduction in analgesic usage, a 33% reduction in antipsychotic prescriptions, and a 21% reduction in antidepressants.

Following the pilot, Renaissance Care, which operates 18 care homes across Scotland and cares for around 750 people, rolled PainChek out across all of its services.

PainChek's integration with healthcare data management provider InterSystems and the implementation phase pilot at Edinburgh Royal Infirmary in Scotland was completed by the Specialist Pain Nurse team, per the filing. The pilot study will now move into phase two to assess the use of PainChek within specific hospital wards, for use by both nurses and healthcare teams.

Its shares were up 4% in recent trading on Wednesday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10